FDA Group “Insider Newsletter” — Discussing FDA Proposed Pharma Quality Metrics, Device Cybersecurity Recommendations + Warning Letter
In the September issue of the FDA Group’s “Insider Newsletter,” Dr. Carmody discusses FDA’s proposed Quality Metrics program, new expectations for device cybersecurity, and a warning letter citing faulty study data. Find the story here.
